HT
IRWD icon

Headlands Technologies’s Ironwood Pharmaceuticals IRWD Stock Holding History

Headlands Technologies’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,185
Closed -$89.4K – 1334
2024
Q4 		$89.4K Sell
20,185
-34,924
-63% -$142K 0.01% 689
2024
Q3 		$227K Buy
55,109
+26,452
+92% +$142K 0.03% 494
2024
Q2 		$187K Buy
28,657
+16,072
+128% +$114K 0.02% 492
2024
Q1 		$110K Buy
+12,585
New +$153K 0.03% 519
2023
Q4 		– Sell
-6,737
Closed -$64.9K – 1110
2023
Q3 		$64.9K Buy
6,737
+5,380
+396% +$52.7K 0.03% 397
2023
Q2 		$14.4K Buy
+1,357
New +$14.6K ﹤0.01% 592

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Headlands Technologies's IRWD Position: Q1 2025 in Review

Headlands Technologies sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 20,185 shares — an estimated $89.4K sold.

Headlands Technologies first reported a position in IRWD in Q2 2023 and held it in 6 quarters. The position peaked at $227K in Q3 2024. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • Headlands Technologies reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Headlands Technologies sold 20,185 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $89.4K.
  • Headlands Technologies first reported a position in Ironwood Pharmaceuticals in Q2 2023 and held it in 6 quarters.
  • Headlands Technologies's Ironwood Pharmaceuticals position peaked at $227K in Q3 2024.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Headlands Technologies's 13F filing for Q1 2025, filed 9 May 2025.